Status:

Grey - after consultant/specialist initiation

Decision Date:

September 2018

Comments

As per SLS criteria in people with erectile dysfunction that have not responded to oral PDE5 inhibitor therapy, after consideration of Alprostadil injection.

Grey Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy

search again